Pinned Tweet
Every microcap we picked this month, with the filed numbers behind each one, in one free PDF.
Sign up and it's yours: kryptonai.io/research/newsle…
2
845
What we got wrong: $SPOK, the week's worst at -8.7%.
We liked the margin jump, $30.1M of free cash flow in a year and no debt. We gave too little weight to software bookings down 28.3% and nine-month free cash flow below the dividend.
Not investment advice.
10
Director buying at our Oct 6 pick $BOTJ:
Watt Foster bought 2,000 shares on the open market Thursday at about $25, about $50K
Not a pre-set plan buy
He now holds 128,360 shares directly
Fourth Bank of the James insider to buy this month, and the biggest by far
Are wealth fees still growing like Q3's 10%?
MICROCAP OF THE DAY: Bank of the James ($BOTJ)
Sleepy Virginia community bank, or a wealth manager hiding inside a lender at 11x earnings?
CHECK OUT OUR PAGE FOR THE FULL REPORT 📈📈
18
Team, Inc. CEO Gary Hill bought another $150K of $TISI on the open market yesterday at $25 a share. That is his second buy this week, after $96K at $22.88 on Monday, and neither was under a pre-set trading plan.
23
CareCloud ($CCLD) had record Q3 net income of $4.7M vs $3.1M, and twelve-month free cash flow was $17.7M, 17.5% of its market value. Without two acquisitions, though, Q3 revenue fell about 3.7%.
Can the billing business grow without buying?
Not investment advice.
108
B&G Foods CEO Robert Mills bought about $250K of $BGS on the open market yesterday at about $3.60. Not a pre-set plan buy, and it lifts his direct stake by about 30%. The company's HR chief sold about $27K of stock the same day.
44
More buying at our Oct 19 pick $PRTA:
10% holder William Scully bought 50,000 shares on the open market Tuesday at about $8.09, about $405K
Not a pre-set plan buy
After 140,000 on 9 Nov at about $8.53
He reported 12.5% in a filing last week
Is the company's own buyback still on?
Prothena ($PRTA) licenses its antibodies for misfolded-protein diseases to Roche, Novo Nordisk and BMS.
A 10% holder has bought about $10.9M of stock in the open market since May, and cash is about two thirds of the market value. Will BMS move PRX019 forward by year-end?
1
88
Sensus Healthcare director Eric Sachetta bought $183K of $SRTS on the open market Tuesday at about $2.24, not a pre-set plan buy. It came a day after the CEO's own buy, and Sachetta also added about 151K shares in August at $3.13 to $3.54. @Sensus_Health
24
Northern Technologies posted record quarterly sales of $26.5M, up about 19%, as its ZERUST industrial rust-prevention line grew 24%. Full-year sales hit a record $96M, and the quarter's net loss narrowed to $0.6M from $1.1M. $NTIC
30
Rocky Brands ($RCKY) grew Q3 net sales 13.3% to $138.8M and cut total debt to $116.0M from $139.0M a year earlier. Without one-time tariff refunds and a free trade zone benefit, Q3 operating income was about $12.2M vs $11.7M.
Is the sales growth enough?
Not investment advice.
11
MaxCyte CEO Maher Masoud bought about $121K of $MXCT on the open market yesterday at roughly $1.21, outside any trading plan. That grows his direct stake about 21%, a week after MaxCyte announced it is buying Akron BioProducts. @MaxCyte_info
1
77
OPAL Fuels co-CEO Adam Comora bought about $61K of $OPAL on the open market Monday and Tuesday at roughly $1.20 to $1.24, lifting his direct stake about 10%. No pre-set plan behind it, and two directors have bought too since Friday. @opalfuels
36
Team, Inc. CEO Gary Hill bought $96K of $TISI on the open market Monday at $22.88 a share, lifting his direct stake by about 8%. No pre-set trading plan behind it, and a director added 500 shares the same day.
28
Three Proficient Auto Logistics insiders bought about $253K of $PAL on the open market Monday and Tuesday. Director Rohit Lal led with $179K at about $2.56, nearly doubling his direct stake. None were pre-set plan buys.
45
Escalade ($ESCA) lifted Q3 gross margin to 29.4% from 28.1% and ended September with $24.5M of cash against $13.1M of debt, down from $20.2M a year earlier. About $11.8M of this year's cash was one-time tariff refunds.
How cheap is it without them?
Not investment advice.
23
i3 Verticals, our Oct 16 pick $IIIV, ended its year:
Adj. EBITDA $58.7M, in the $57M-$60M guide
Recurring revenue run rate $177M, +7.1%
2027 EBITDA guide $61.25M-$68.75M
Q4 net loss $5.1M, with a $6.1M earn-out charge
How much of 2027 growth is organic?
i3 Verticals ($IIIV) sells software and payment tools to courts, transportation agencies, utilities and schools.
The founder bought about $962K of stock in May at $19.23. It's $16.60 now, with 18% fewer shares than a year ago. We think the market is pricing one bad quarter.
70
Sensus Healthcare CEO Joseph Sardano bought $72K of $SRTS on the open market yesterday at about $2.40. Not a pre-set plan buy, and his second since August, when he paid about $3.02. @Sensus_Health
63
Natural Gas Services Group CEO Justin Jacobs bought $85.8K of $NGS on the open market yesterday at about $28.60. Not a pre-set plan buy. Two directors added about $107K more on Friday.
66
HireQuest ($HQI) fell 23.6% on 13 Nov after Q3: operating income $1.9M vs $2.4M, with a $1.1M repossession loss. Nine-month operating income rose 37.4% to $6.7M; HireQuest Direct royalties rose 10.9%.
Can HireQuest Direct and Snelling keep growing?
Not investment advice.
1
64
Full write-up, with the quarterly table and the filings: kryptonai.io/research/picks/…
33


























